品质为先。

     

APAC MARKETS

我们设法促进高度专业化和具有科学价值的领域的发展,以提高医疗保健的标准。

发现更多关于美纳里尼集团的信息

30 多年来,美纳里尼一直致力于推动研发,为受严重健康问题影响的患者提供创新且有效的药物和医疗保健解决方案。

在13个主要市场获取进入亚太地区所有主要市场的单点式入口。

分享您的合作意向

充分利用我们的全渠道方法使您的品牌在亚太地区增长。

MARKETS

亚太地区的医疗行业正在快速增长。美纳里尼亚太隶属于世界领先的意大利生物制药公司,在该地区13个主要市场拥有强大的布局。

作为众多全球医疗保健公司的首选合作伙伴,我们参与整个药品开发生命周期,挖掘增长机会并扩大其品牌影响力。在此过程中,我们还为医务工作者和患者提供优质医疗产品和技术支持,以提高标准并为未来缔造健康生活。

我们的亚太地区总部

A. MENARINI ASIA-PACIFIC HOLDINGS PTE LTD
A. MENARINI ASIA-PACIFIC PRIVATE LIMITED
A. MENARINI SINGAPORE PTE LTD
A. MENARINI BIOMARKERS SINGAPORE PTE LTD

30 Pasir Panjang Road,
Mapletree Business City,
#08-32 Singapore 117440
Tel: +65-6494-7200
Fax: +65-6999-1787

 

新闻

2018 - 10 - 15

Two-thirds of Australians surveyed affected by mild anxiety1

A new survey has revealed that of those Australians living with mild anxiety, over 90% have experienced symptoms in the last 4 weeks

For these Australians that suffer from mild anxiety,1 the ‘always-on' and fast-paced nature of Aussie life appears to be a significant contributor with 90% admitting that they have experienced at least one symptom in the past month.1

The survey looked at the incidence of mild anxiety, and also explored Australians' attitudes towards treatment and the barriers that currently exist to seeking help for mild anxiety symptoms.

Anxiety is the most common mental health condition in Australia,2 and on average one in four people will experience an anxiety disorder at some stage in their life.3 If left untreated mild anxiety can last for a long time and can quickly become exhausting and debilitating.4 It is important to be able to identify when that anxious feeling is a little more than just worry or stress. Symptoms of mild anxiety may include feeling restless, easily tired, irritable, experiencing muscle pain, disturbed sleep, difficulty concentrating and finding it difficult to stop worrying.5 NOTE: Patients experiencing 3 or more of these symptoms should consult a healthcare professional to exclude other conditions.

From the survey, the most common symptoms of mild anxiety that Australians experience are disturbed sleep (62%), anxious moods (53%) and recurring thoughts (48%).1

Family-related issues are one the biggest triggers of symptoms related to mild anxiety. Research has found that dealing with family related issues or situations are the number one trigger of mild anxiety related symptoms for Australians,1 and this is especially true for females.3

Two in three sufferers have sought professional help and nine in ten Australians have made lifestyle changes to help manage their symptoms.1 Most commonly people have tried to sleep for at least seven – eight hours per night (68%), increased their exercise (64%) or sought relaxation practices (54%).1 However, there are many barriers to seeking medical help.

The survey uncovered several alarming myths around the condition and treatment of mild anxiety, including the fact that over half of all Aussies believe that it is not necessary to seek any medical treatment for mild anxiety.1

General Practitioner Dr Ginni Mansberg comments: "Symptoms of mild anxiety are incredibly common but often very difficult to manage. While daily exercise, cutting back on drugs and alcohol and dietary modifications, can be effective, they're hard to do, especially when you're feeling stressed. Of course psychological therapies such as mindfulness, relaxation techniques, and cognitive behavioural therapies are really effective, they take time, commitment and often lots of money to work".

The survey results coincide with the launch of Seremind, a new non-prescription option for Australians with mild anxiety.  Seremind contains Silexan, a standardized, highly purified lavender oil preparation which relieves mild anxiety symptoms. Seremind has been clinically tested to reduce the symptoms of mild anxiety within two weeks with daily usage, and improve sleep quality in six weeks.

Importantly, Seremind relieves symptoms of mild anxiety with a low incidence of side effects. This is significant as 73% of Aussies said they would seek help for mild anxiety if the treatments available didn't have major side effects1 and a further 62% would seek help if they could receive treatment without having to see a doctor or need a prescription.1

Dr. Mansberg added, "Australians experiencing mild anxiety needn't feel alone. We're seeing ever greater awareness of the condition and new options are being studied all the time. People experiencing symptoms of mild anxiety or who would like additional information should speak to their healthcare professional."

 

1Seremind Anxiety Survey
2Australian Bureau of Statistics. (2008). National Survey of Mental Health and Wellbeing: Summary of Results, 2007. Cat. no. (4326.0). Canberra: ABS.
3Beyond Blue Handbook. A guide to what works for anxiety. Page 7.
4Healthline. (2018). Complications from Untreated Anxiety. [online] Available at: https://www.healthline.com/health/anxiety-complications#related-conditions [Accessed 14 Aug. 2018].
5Seremind Product Insert February 2018

If you'd like to know more about Menarini, feel free to download our PDF files here.